Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation

Por Hernæs, Kjersti Helene, Smeland, Knut B., Fagerli, Unn-Merete, Kiserud, Cecilie E.
Publicado no BMC Cancer (2021)

c-Met signaling promotes IL-6-induced myeloma cell proliferation

Por Hov, Håkon, Tian, Erming, Holien, Toril, Holt, Randi Utne, Våtsveen, Thea K, Fagerli, Unn-Merete, Waage, Anders, Børset, Magne, Sundan, Anders
Publicado em 2009

Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

Por Hjort, Magnus Aassved, Hov, Håkon, Abdollahi, Pegah, Vandsemb, Esten Nymoen, Fagerli, Unn-Merete, Lund, Bendik, Slørdahl, Tobias Schmidt, Børset, Magne, Rø, Torstein Baade
Publicado no Exp Hematol Oncol (2018)

Runaway Train: A Leaky Radiosensitive SCID with Skin Lesions and Multiple Lymphomas

Por Fevang, Børre, Fagerli, Unn Merete, Sorte, Hanne, Aarset, Harald, Hov, Håkon, Langmyr, Marit, Keil, Thomas Morten, Bjørge, Ellen, Aukrust, Pål, Stray-Pedersen, Asbjørg, Gedde-Dahl, Tobias
Publicado no Case Reports Immunol (2018)

High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis

Por Brenne, Anne-Tove, Fagerli, Unn-Merete, Shaughnessy, John D, Våtsveen, Thea Kristin, Rø, Torstein Baade, Hella, Hanne, Zhan, Fenghuang, Barlogie, Bart, Sundan, Anders, Børset, Magne, Waage, Anders
Publicado em 2009

Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: result...

Por Pulczynski, Elisa J., Kuittinen, Outi, Erlanson, Martin, Hagberg, Hans, Fosså, Alexander, Eriksson, Mikael, Nordstrøm, Marie, Østenstad, Bjørn, Fluge, Øystein, Leppä, Sirpa, Fiirgaard, Bente, Bersvendsen, Hanne, Fagerli, Unn-Merete
Publicado no Haematologica (2015)

Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway

Por Smeland, Knut B., Kiserud, Cecilie E., Lauritzsen, Grete F., Fagerli, Unn-Merete, Falk, Ragnhild S., Fluge, Øystein, Fosså, Alexander, Kolstad, Arne, Loge, Jon H., Maisenhölder, Martin, Kvaløy, Stein, Holte, Harald
Publicado no Haematologica (2015)

Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells

Por Fagerli, Unn-Merete, Holt, Randi U., Holien, Toril, Vaatsveen, Thea K., Zhan, Fenghuang, Egeberg, Kjartan W., Barlogie, Bart, Waage, Anders, Aarset, Harald, Dai, Hong Yan, Shaughnessy, John D., Sundan, Anders, Børset, Magne
Publicado em 2008

Phase 1/2a study of (177)Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma

Por Kolstad, Arne, Illidge, Tim, Bolstad, Nils, Spetalen, Signe, Madsbu, Ulf, Stokke, Caroline, Blakkisrud, Johan, Løndalen, Ayca, O'Rourke, Noelle, Beasley, Matthew, Jurczak, Wojciech, Fagerli, Unn-Merete, Kaščák, Michal, Bayne, Mike, Obr, Aleš, Dahle, Jostein, Rojkjaer, Lisa, Pascal, Veronique, Holte, Harald
Publicado no Blood Adv (2020)

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

Por Eskelund, Christian Winther, Dimopoulos, Kostas, Kolstad, Arne, Glimelius, Ingrid, Räty, Riikka, Gjerdrum, Lise Mette Rahbek, Sonnevi, Kristina, Josefsson, Pär, Nilsson-Ehle, Herman, Bentzen, Hans H. N., Fagerli, Unn Merete, Kuittinen, Outi, Haaber, Jacob, Niemann, Carsten Utoft, Pedersen, Lone Bredo, Larsen, Maria Torp, Geisler, Christian Hartmann, Hutchings, Martin, Jerkeman, Mats, Grønbæk, Kirsten
Publicado no Hemasphere (2020)

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Por Leppä, Sirpa, Jørgensen, Judit, Tierens, Anne, Meriranta, Leo, Østlie, Ingunn, de Nully Brown, Peter, Fagerli, Unn-Merete, Larsen, Thomas Stauffer, Mannisto, Susanna, Munksgaard, Lars, Maisenhölder, Martin, Vasala, Kaija, Meyer, Peter, Jerkeman, Mats, Björkholm, Magnus, Fluge, Øystein, Jyrkkiö, Sirkku, Liestøl, Knut, Ralfkiaer, Elisabeth, Spetalen, Signe, Beiske, Klaus, Karjalainen-Lindsberg, Marja-Liisa, Holte, Harald
Publicado no Blood Adv (2020)

Nordic MCL3 study: (90)Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma

Por Kolstad, Arne, Laurell, Anna, Jerkeman, Mats, Grønbæk, Kirsten, Elonen, Erkki, Räty, Riikka, Pedersen, Lone Bredo, Loft, Annika, Bogsrud, Trond Velde, Kimby, Eva, Hansen, Per Boye, Fagerli, Unn-Merete, Nilsson-Ehle, Herman, Lauritzsen, Grete Fossum, Lehmann, Anne Kristine, Sundstrom, Christer, Karjalainen-Lindsberg, Marja-Liisa, Ralfkiaer, Elisabeth, Ehinger, Mats, Delabie, Jan, Bentzen, Hans, Schildt, Jukka, Kostova-Aherdan, Kamelia, Frederiksen, Henrik, Brown, Peter de Nully, Geisler, Christian H.
Publicado em 2014